Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine GITS in mild-to-moderate hypertension
NCT02641821Phase 4Unknown
- Sponsor
- Peking University First Hospital
- Start
- Oct 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nifedipine in hypertension (HTN), sponsored by Peking University First Hospital. Primary endpoints: Control rate of hypertension evaluated by office blood pressure at 8 weeks and Control rate of hypertension evaluated by office blood pressure at 4 weeks. Status: unknown.
02
Drugs
nifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02641821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641821.